Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 16.85
+0.20 (1.20%)
At close: Aug 27, 2026
Vytrus Biotech Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 127 | 64 | 16 | 13 | 23 | - | |
Market Cap Growth | 178.23% | 294.97% | 29.02% | -46.26% | - | - |
Enterprise Value | 124 | 62 | 16 | 14 | 23 | - |
Last Close Price | 16.85 | 8.55 | 2.16 | 1.86 | 3.40 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 43.72 | 22.21 | 15.95 | 23.17 | 38.81 | - |
Forward PE | - | 20.43 | 21.98 | 11.97 | 26.21 | - |
PS Ratio | 13.07 | 6.64 | 2.67 | 2.69 | 5.24 | - |
PB Ratio | 12.29 | 6.24 | 2.23 | 2.38 | 4.94 | - |
P/TBV Ratio | 23.66 | 12.02 | 5.06 | 7.59 | 14.68 | - |
P/FCF Ratio | 43.88 | 22.29 | 9.35 | 16.55 | 38.78 | - |
P/OCF Ratio | 32.48 | 16.50 | 8.83 | 13.96 | 22.90 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 12.84 | 6.45 | 2.64 | 2.91 | 5.20 | - |
EV/EBITDA Ratio | 36.68 | 18.41 | 13.67 | 22.96 | 30.92 | - |
EV/EBIT Ratio | 39.43 | 19.79 | 16.34 | 33.82 | 38.42 | - |
EV/FCF Ratio | 43.11 | 21.64 | 9.24 | 17.93 | 38.49 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.12 | 0.12 | 0.24 | 0.39 | 0.21 | 0.22 |
Debt / EBITDA Ratio | 0.37 | 0.37 | 1.51 | 3.49 | 1.31 | 0.94 |
Debt / FCF Ratio | 0.43 | 0.43 | 1.02 | 2.72 | 1.63 | 4.09 |
Net Debt / Equity Ratio | -0.21 | -0.21 | -0.10 | 0.18 | 0.06 | -0.08 |
Net Debt / EBITDA Ratio | -0.65 | -0.65 | -0.64 | 1.63 | 0.35 | -0.36 |
Net Debt / FCF Ratio | -0.76 | -0.76 | -0.43 | 1.27 | 0.43 | -1.56 |
Asset Turnover | 0.75 | 0.75 | 0.60 | 0.54 | 0.59 | 0.53 |
Inventory Turnover | 1.47 | 1.47 | 1.07 | 0.72 | 1.02 | 1.11 |
Quick Ratio | 2.67 | 2.67 | 2.60 | 1.90 | 0.99 | 1.92 |
Current Ratio | 3.03 | 3.03 | 3.03 | 2.46 | 1.33 | 2.26 |
Return on Equity (ROE) | 32.91% | 32.91% | 16.23% | 10.85% | 13.44% | 11.45% |
Return on Assets (ROA) | 15.29% | 15.29% | 6.02% | 2.92% | 4.99% | 3.82% |
Return on Invested Capital (ROIC) | 36.07% | 39.94% | 15.39% | 7.17% | 13.62% | 11.25% |
Return on Capital Employed (ROCE) | 24.50% | 24.50% | 10.00% | 4.90% | 9.00% | 6.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.29% | 4.50% | 6.27% | 4.32% | 2.58% | - |
FCF Yield | 2.28% | 4.49% | 10.70% | 6.04% | 2.58% | - |
Buyback Yield / Dilution | 0.10% | 0.10% | -11.71% | - | - | -0.43% |